FORWARD PHARMA A/S: Financial statements 2019
CVR: 28865880
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,969,155 and a net result of DKK -28,465,258 compared with DKK -54,294,876 the year before. Equity in the 2019 report amounted to DKK 515,926,854. The solvency ratio was 84.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -5,969,155
- Profit/Loss
- DKK -28,465,258
- Equity
- DKK 515,926,854
- Total Assets
- DKK 613,146,265
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
| 2017 | 1.3 mia. USD | - | 880.2 mio. USD | 89.4 mio. USD | - |
| 2016 | - | - | 2 mio. USD | 189.7 mio. USD | - |
| 2015 | - | - | -51.1 mio. USD | 176.7 mio. USD | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
FORWARD PHARMA A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -54,294,876.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.